75 related articles for article (PubMed ID: 16218001)
1. Pleural effusion as presentation of metastatic adenocarcinoma of prostate.
de Paso Mora PG; Ríos BJ; Pascual Pareja FJ; Castillo Torres C; Pinto Marín A; Sendino Revuelta A; Vázquez RJ
South Med J; 2005 Sep; 98(9):959-60. PubMed ID: 16218001
[No Abstract] [Full Text] [Related]
2. [Prostatic syndrome and pleural effusion: are they different diseases?].
Ortiz de Saracho y Bobo J; Pantoja Zarza L; Cano Pérez JL; Parra Muntaner L; Madrid J; Yagüe Zapatero E; Albors L
Arch Esp Urol; 2001; 54(1):64-6. PubMed ID: 11296674
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma prostate presenting as pleural effusion with metastatic pleural mass.
Gogia A; Agarwal PK; Vasdev N; Sachar VP
J Postgrad Med; 2004; 50(4):310-1. PubMed ID: 15623982
[No Abstract] [Full Text] [Related]
4. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions.
Renshaw AA; Nappi D; Cibas ES
Diagn Cytopathol; 1996 Aug; 15(2):103-7. PubMed ID: 8872430
[TBL] [Abstract][Full Text] [Related]
5. Malignant pleural effusion from prostatic adenocarcinoma resolved with hormonal therapy.
Carrascosa M; Perez-Castrillon JL; Mendez MA; Cillero L; Valle R
Chest; 1994 May; 105(5):1577-8. PubMed ID: 8181358
[TBL] [Abstract][Full Text] [Related]
6. [Utility of prostate-specific antigen in pleural fluid for the diagnosis of metastatic effusion secondary to prostate cancer].
Sánchez Merino JM; Quintana González JI; Toribio Sánchez CM; Gómez Cisneros SC; Parra Muntaner L; García Alonso J
Actas Urol Esp; 2002; 26(7):513-4. PubMed ID: 12224436
[TBL] [Abstract][Full Text] [Related]
7. Use of pleural fluid prostate specific antigen in the diagnosis of malignant effusion from metastatic prostate cancer.
Go RS; Klee GG; Richardson RL
J Urol; 2000 Aug; 164(2):459. PubMed ID: 10893618
[No Abstract] [Full Text] [Related]
8. Prostatic adenocarcinoma diagnosed by prostate-specific antigen analysis of pleural fluid.
Brown GA; Ginsberg PC; Harkaway RC
Urol Int; 1998; 60(3):197-8. PubMed ID: 9644796
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of prostate cancer found primarily from lung metastatic lesions].
Sugama Y; Uji M; Matsushita H
Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):733-8. PubMed ID: 14584395
[TBL] [Abstract][Full Text] [Related]
10. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
Bartziota EV
Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
[TBL] [Abstract][Full Text] [Related]
11. Massive pleural effusion without bony involvement: an unusual presentation of advanced carcinoma prostate.
Ansari MS; Nabi G; Seth A
Indian J Cancer; 2002; 39(3):123-4. PubMed ID: 12928569
[TBL] [Abstract][Full Text] [Related]
12. Metastatic prostatic adenocarcinoma-diagnosed by bronchoalveolar lavage and tumour marker determination.
Verstraeten A; Sault MC; Wallaert B; Lemonnier P; Gosselin B; Tonnel AB
Eur Respir J; 1991 Nov; 4(10):1296-8. PubMed ID: 1725158
[TBL] [Abstract][Full Text] [Related]
13. [Black pleural fluid].
Rojas-Solano JR; Light RW; Brenes-Dittel A
Arch Bronconeumol; 2009 Feb; 45(2):103-4. PubMed ID: 19232273
[No Abstract] [Full Text] [Related]
14. Severe flare-up in a prostate cancer patient treated with luteinizing hormone-releasing hormone analogue depot.
Shimizu T; Shibata Y; Uchida T; Satoh J
Hinyokika Kiyo; 1993 Oct; 39(10):953-5. PubMed ID: 8266863
[TBL] [Abstract][Full Text] [Related]
15. Pleural metastasis from soft tissue sarcoma.
Satoh H; Sekizawa K
Tuberk Toraks; 2008; 56(4):485; author reply 486. PubMed ID: 19123089
[No Abstract] [Full Text] [Related]
16. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
17. The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms.
Copeland JN; Amin MB; Humphrey PA; Tamboli P; Ro JY; Gal AA
Am J Clin Pathol; 2002 Apr; 117(4):552-7. PubMed ID: 11939729
[TBL] [Abstract][Full Text] [Related]
18. Increase of ascites and pleural effusion misleading assessment of antitumor response to erlotinib in adenocarcinoma of the lung.
Tachihara M; Misa K; Uematsu M; Minemura H; Katsuura Y; Ishida T; Munakata M
J Clin Oncol; 2011 Aug; 29(23):e675-7. PubMed ID: 21690480
[No Abstract] [Full Text] [Related]
19. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
Kim JH; Kim YS; Choi YD; Lee JS; Park CS
Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739
[TBL] [Abstract][Full Text] [Related]
20. Unusual cytologic manifestation of small-cell lung cancer in associated pleural effusion.
Smith R; Nguyen GK
Diagn Cytopathol; 2004 Apr; 30(4):266-7. PubMed ID: 15048963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
